Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

DNA discovery could help treat Marek's disease
Scientists identified regions of chicken DNA that are seen to play a role in disease resistance.
Scientists identify genetic regions in chickens associated with resistance.

Researchers at the University of Edinburgh's Roslin Institute have identified regions of chicken DNA associated with resistance to Marek's disease.

Scientists say the discovery, reported in the journal Genes, could pave the way to new therapies or techniques to manage the condition, which costs the global poultry industry some US$ 2 billion every year.The findings also reveal details behind susceptibility to the virus, which could lead to more precise selective breeding strategies.

“Marek’s disease is devastating to flocks worldwide as well as the economy, and current vaccination can only partially control it,” explains Dr Jaqueline Smith, study lead at the Roslin Institute.“Our study identifies regions of the genome associated with resistance, which could be used for mitigating the effects of the virus through selective breeding, improved vaccine design, or future gene-editing technologies.”

In the study, scientists identified regions of chicken DNA that are seen to play a role in disease resistance. Their approach included comparing the DNA of two groups of commercial egg-laying chickens which differed in their resistance to Marek’s disease virus.

The team analysed genetic information from infected chicks and identified variations associated with resistance in the DNA of multiple commercial chicken lines. They also investigated the genetic association with mortality in the infected offspring of egg-laying birds.

Outcomes from this research are the first to provide such a large-scale, high-resolution analysis of genes underlying resistance to the virus in birds relevant to the poultry industry.

Because the tumours caused by Marek’s disease virus have similarities to human lymphoma, researchers hope that their findings may also be able to increase understanding of human cancers.

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
Applications open for BEVA Back in the Saddle

The British Equine Veterinary Association (BEVA) has opened applications for its 'Back in the Saddle' coaching programme.

The online scheme offers structured group coaching for members wanting to reflect on their career path and regain clarity. Members may be returning to work after leave, uncertain about next steps or reassessing direction.

Attendees will benefit from impartial guidance and practical tools to support their professional development. Members are encouraged to take a 'proactive, future-focused approach' to their careers.

The sessions, taking place on Wednesdays from 7.30pm-9pm, are open to BEVA members with more than five years' experience. The first session takes place on Wednesday, 3 June 2026.

Applications will close on Wednesday, 27 May 2026.